Abstract
Melasma is a common acquired disorder of symmetrical hyperpigmentation, classically manifested as brown patches on the face. It affects both genders but is primarily seen in women, particularly those with skin of color. Its etiology is unknown, but risk factors include genetic predisposition, ultraviolet light exposure, pregnancy, and exogenous hormones. Diagnosis is made clinically, aided by Wood’s lamp examination and absence of inflammation. Treatment is important, as melasma may be cosmetically disfiguring and chronic with significant effect on quality of life. Broad-spectrum sunscreen and topical depigmenting agents, such as triple combination therapy, can be efficacious in affected patients.
Keywords
Atopic Dermatitis Lichen Planus Kojic Acid Intense Pulse Light Acanthosis Nigricans
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
- 1.Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65(4):689–97; quiz 698.PubMedCrossRefGoogle Scholar
- 2.Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, Voorhees JJ. Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol. 1994;130(6):727–33.PubMedCrossRefGoogle Scholar
- 3.Chan R, Park KC, Lee MH, Lee ES, Chang SE, Leow YH, Tay YK, Legarda-Montinola F, Tsai RY, Tsai TH, Shek S, Kerrouche N, Thomas G, Verallo-Rowell V. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01 %, hydroquinone 4 %, tretinoin 0.05 %) compared with hydroquinone 4 % cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159(3):697–703.PubMedGoogle Scholar
- 4.Bansal C, Naik H, Kar HK, Chauhan A. A comparison of low-fluence 1064-nm Q-switched Nd: YAG laser with topical 20 % azelaic acid cream and their combination in melasma in Indian patients. J Cutan Aesthet Surg. 2012;5(4):266–72.PubMedCentralPubMedCrossRefGoogle Scholar
- 5.Salem A, Gamil H, Ramadan A, Harras M, Amer A. Melasma: treatment evaluation. J Cosmet Laser Ther. 2009;11(3):146–50.PubMedCrossRefGoogle Scholar
- 6.Farshi S. Comparative study of therapeutic effects of 20 % azelaic acid and hydroquinone 4 % cream in the treatment of melasma. J Cosmet Dermatol. 2011;10(4):282–7.PubMedCrossRefGoogle Scholar
- 7.Lieu TJ, Pandya AG. Melasma quality of life measures. Dermatol Clin. 2012;30(2):269–80. viii.PubMedCrossRefGoogle Scholar
- 8.Sheth VM, Pandya AG. Melasma: a comprehensive update: part II. J Am Acad Dermatol. 2011;65(4):699–714; quiz 715.PubMedCrossRefGoogle Scholar
- 9.Estrada Castañón R, Andersson N. Community dermatology and the management of skin diseases in developing countries. Trop Doct. 1992;22 Suppl 1:3–6.PubMedGoogle Scholar
- 10.Rivas S, Pandya AG. Treatment of melasma with topical agents, peels and lasers: an evidence-based review. Am J Clin Dermatol. 2013;14(5):359–76.PubMedCrossRefGoogle Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 2014